−2.54DKK
−12.10 MDKK
5.58 MDKK
2.67 M
About VIROGATES A/S
Sector
Industry
CEO
Jakob Knudsen
Website
Headquarters
Birkerod
Employees (FY)
10
Founded
2000
ISIN
DK0061030574
FIGI
BBG00L2R5H35
ViroGates A/S develops and markets prognostic products for the healthcare sector. Its products include suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic ELISA. The products of the company are used for the prognosis of lifestyle-related diseases, such as cardiovascular disease, type 2 diabetes, cancer, and emergency services to make a clinical decision on hospitalization or discharge of acute medical patients. The company was founded by Jesper Eugen-Olsen, Jørgen Axel Thorball, and Peter James Arthur Benson in 2001 and is headquartered in Birkerod, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VIRO is 6.88 DKK — it has increased by 6.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange VIROGATES A/S stocks are traded under the ticker VIRO.
VIROGATES A/S is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
VIRO stock is 7.37% volatile and has beta coefficient of −0.62. Check out the list of the most volatile stocks — is VIROGATES A/S there?
VIRO earnings for the last quarter are −0.76 DKK per share, whereas the estimation was −0.66 DKK resulting in a −15.29% surprise. The estimated earnings for the next quarter are −0.87 DKK per share. See more details about VIROGATES A/S earnings.
VIROGATES A/S revenue for the last quarter amounts to 3.20 M DKK despite the estimated figure of 5.47 M DKK. In the next quarter revenue is expected to reach 3.28 M DKK.
Yes, you can track VIROGATES A/S financials in yearly and quarterly reports right on TradingView.
VIRO stock has risen by 14.29% compared to the previous week, the month change is a 5.75% fall, over the last year VIROGATES A/S has showed a 62.35% decrease.
VIRO net income for the last quarter is −3.32 M DKK, while the quarter before that showed −2.13 M DKK of net income which accounts for −55.78% change. Track more VIROGATES A/S financial stats to get the full picture.
Today VIROGATES A/S has the market capitalization of 41.76 M, it has decreased by 0.83% over the last week.
No, VIRO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VIRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIROGATES A/S stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 10.00 employees. See our rating of the largest employees — is VIROGATES A/S on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIROGATES A/S technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIROGATES A/S stock shows the sell signal. See more of VIROGATES A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIROGATES A/S EBITDA is −13.06 M DKK, and current EBITDA margin is −224.38%. See more stats in VIROGATES A/S financial statements.